Panitumumab (anti-EGFR)

Tax included
Panitumumab (anti-EGFR) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab (anti-EGFR) inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab (anti-EGFR) can be used in the research of cancers, such as colon cancer.
HY-P99041A

Data sheet

Size
Multiple sizes
Reactivity
EGFR
Application
Cancer-Kinase/protease